Nordimet is indicated for the treatment of:


- active rheumatoid arthritis in adult patients,


- polyarthritic forms of severe, active juvenile idiopathic   arthritis (JIA), when the response to nonsteroidal

anti-inflammatory drugs (NSAIDs) has been inadequate,


- severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet A (PUVA), and retinoids,


- severe psoriatic arthritis in adult patients.



Privacy Statement

 Terms of Use

Contact Us

IE/21/NOR/005-00      Date of Prep: April 2021